Ross, David
Royal Adelaide Hospital · Flinders University · Flinders Medical Centre · South Australian Health and Medical Research Institute · The University of Adelaide
5 papers on CoChatORCID 0000-0001-7171-2935
Most cited papers
- Verified
Periodontal Ehlers-Danlos Syndrome Is Caused by Mutations in C1R and C1S , which Encode Subcomponents C1r and C1s of Complement
Kapferer-Seebacher, I., Pepin, M., Werner, R., Aitman, T. J., Nordgren, A., Stoiber, H., Thielens, N., Gaboriaud, C., Amberger, A., Schossig, A., et al. (2016) · The American Journal of Human Genetics
Complement system in diseasesOral microbiology and periodontitis research
Cited by 123
- Verified
Treatment-free remission following frontline nilotinib in patients with chronic phase chronic myeloid leukemia: 5-year update of the ENESTfreedom trial
Radich, J. P., Hochhaus, A., Masszi, T., Hellmann, A., Stentoft, J., Casares, M. T. G., García-Gutiérrez, J. V., Conneally, E., le Coutre, P. D., Gattermann, N., et al. (2021) · Leukemia
Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research
Cited by 91
- Verified
Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND study
Yeung, D. T., Shanmuganathan, N., Reynolds, J., Branford, S., Walia, M., Yong, A. S. M., Shortt, J., Chee, L., Viiala, N., Cunningham, I., et al. (2024) · Blood
Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research
Cited by 27
- Verified
Strong Association between Cancer Gene Variants at Diagnosis, Especially ASXL1, and Emergence of Kinase Domain Mutation-Driven Resistance in CML Patients Despite Frontline Treatment with More Potent BCR::ABL1 Inhibitors
Shanmuganathan, N., Wadham, C., Yeung, D. T., Shahrin, N. H., Fernandes, A., Maqsood, M., Kok, C. H., Saunders, V. A., Pagani, I. S., Kenyon, R., et al. (2024) · Blood
Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research
Cited by 12
- Verified
Disease-modifying activity of navtemadlin correlates with clinical responses in a randomized, multicenter, global phase 3 study (BOREAS) in JAK-inhibitor relapsed/refractory myelofibrosis
Mascarenhas, J. O., Bose, P., Hou, H.-A., Homenda, W., Ross, D., Mohan, S. R., Kiladjian, J.-J., Al-Ali, H. K., Perkins, A., Khalina, Y., et al. (2024) · Blood
Myeloproliferative Neoplasms: Diagnosis and TreatmentAcute Myeloid Leukemia Research
Cited by 8
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free